Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme

Organisation Organisation [iito] Business Intelligence
Products Product Life-Sciences-Europe.com – [LSE] The European Life Sciences Web Portal
  Product 2 Life-Sciences-USA.com – [LSUS] The Transatlantic Life Sciences Web Portal
     


What does [iito] stand for?


The answer is:

[i]nstitutions
[i]nformation
[t]echnologies
[o]rganisation!


All [iito] life science business portals run on a database system that has been designed to capture the development of markets and economies. The database has been developed by an economist and its structure is based on property rights theory and new and old institutional economics.

The life sciences industry is “just” the main application of the [iito] system today, while the system has been developed in a totally different context.


What are property rights?

To put it simple: property rights are rights to action at a specific time, in a particular place and social context. They may be formalised like a patent, legal ownership, or a voting right; they may be informal like culture or habits. They never exist as such, but always describe relations among human beings with regard to accepted and possible actions in a society.


What are institutions?

In a (very) short way: these are established patterns of actions, that can be expected with some kind of probability in a certain context. These insitutions (ideally) should support and facilitate the efficient exchange of property rights.


How can property rights be transferred in the life sciences industry within the institutional setting of capitalist global markets with national legal systems?


A simple example:

Four possible ways to acquire the right to sell a drug in the market.


1. Acquisition of company:

You can buy the company, that has the rights to the drug.


2. Acquisition of assets

You can acquire all assets related to the drug from another company.


3. Licensing

You can license the rights to sell the drug.


4. Own development

You can develop the drug yourself and sell it.



The [iito] database system is designed to capture all those kinds of transfers of property rights named above and more. Certainly you need more, as your drug has to be, e.g., approved and (hopefully) reimbursed, to be sold in a particular market.


More on [iito]’s move in the life science business portal markets in another “Special Feature”, soon to come.



This special feature has been sponsored by [iito] Business Intelligence, Bremen, Germany.

   
Record changed: 2019-05-31

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for [iito] Business Intelligence


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top